Table 1 Basic TNBC and Her2 positive patient characteristics

# Total

76 (100%)

96 (100%)

Median patient age

54.3 y (range 28 – 83)

54.0 (range 24 – 79)

# Grading 1

1 (1.3%)

0 (0%)

# Grading 2

20 (26.3%)

39 (40.6%)

# Grading 3

54 (71.1%)

56 (58.3%)

# Grading unknown

1 (1.3%)

1 (1.0%)

# Stage 1

17 (22.4%)

17 (17.7%)

# Stage 2

41 (53.9%)

42 (43.8%)

# Stage 3

9 (11.8%)

22 (22.9%)

# Stage 4

4 (5.3%)

13 (13.5%)

# Staging unknown

5 (6.6%)

2 (2.1%)

pNO (initial diagnosis)

41 (53.9%)

33 (34.3%)

pN+

29 (38.2%)

58 (60.4%)

pNX

6 (7.9%)

5 (5.2%)

Metastatic patients (initial diagnosis)

14 (18.4%)

13 (13.5%)

Median OS [months]

55.8 (range 0.9 – 238)

41.2 (range 13.0 – 193.5)

Median EFS [months]

50.9 (range 0.9 – 197.9)

33.3 (range 7.8 – 114)